{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T17:45:52Z","timestamp":1710351952271},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,21]]},"DOI":"10.7759\/cureus.25196","type":"journal-article","created":{"date-parts":[[2022,5,22]],"date-time":"2022-05-22T04:40:00Z","timestamp":1653194400000},"source":"Crossref","is-referenced-by-count":2,"title":["A Case Series of SARS-CoV-2 Omicron Variant in Patients With Acute Leukemia"],"prefix":"10.7759","author":[{"given":"Elrazi A","family":"Ali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed A","family":"Alamin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Abu-Tineh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Awni","family":"Alshurafa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waail","family":"Rozi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed A","family":"Yassin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.23750\/abm.v91i4.10540","article-title":"Prevalence, clinical manifestations, and biochemical data of hypertensive versus normotensive symptomatic patients with COVID- 19: a comparative study","volume":"91","author":"De Sanctis V","year":"2020","unstructured":"De Sanctis V. Prevalence, clinical manifestations, and biochemical data of hypertensive versus normotensive symptomatic patients with COVID- 19: a comparative study. Acta Biomed. 2020, 91:e2020164. 10.23750\/abm.v91i4.10540","journal-title":"Acta Biomed"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.23750\/abm.v91i3.10214","article-title":"Prevalence, clinical manifestations, and biochemical data of type 2 diabetes mellitus versus nondiabetic symptomatic patients with COVID-19: a comparative study","volume":"91","author":"Soliman AT","year":"2020","unstructured":"Soliman AT, Prabhakaran Nair A, Al Masalamani MS, et al.. Prevalence, clinical manifestations, and biochemical data of type 2 diabetes mellitus versus nondiabetic symptomatic patients with COVID-19: a comparative study. Acta Biomed. 2020, 91:e2020010. 10.23750\/abm.v91i3.10214","journal-title":"Acta Biomed"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.925932","article-title":"A case of fulminant liver failure in a 24-year-old man with coinfection with hepatitis B virus and SARS-CoV-2","volume":"21","author":"Ali E","year":"2020","unstructured":"Ali E, Ziglam H, Kohla S, Ahmed M, Yassin M. A case of fulminant liver failure in a 24-year-old man with coinfection with hepatitis B virus and SARS-CoV-2. Am J Case Rep. 2020, 21:e925932. 10.12659\/AJCR.925932","journal-title":"Am J Case Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.3731","article-title":"Severe SARS-CoV-2 infection presenting with acute kidney injury and diabetic ketoacidosis complicated by pancreatitis in a 53-year man with hypertension","volume":"9","author":"Ali E","year":"2021","unstructured":"Ali E, Badawi M, Ahmed A, Abdelmahmuod E, Ibrahim W. Severe SARS-CoV-2 infection presenting with acute kidney injury and diabetic ketoacidosis complicated by pancreatitis in a 53-year man with hypertension. Clin Case Rep. 2021, 9:1202-6. 10.1002\/ccr3.3731","journal-title":"Clin Case Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.4568","article-title":"SARS-CoV-2 and guttate psoriasis: a case report and review of literature","volume":"9","author":"Ali E","year":"2021","unstructured":"Ali E, Mohamed A, Abuodeh J, et al.. SARS-CoV-2 and guttate psoriasis: a case report and review of literature. Clin Case Rep. 2021, 9:e04568. 10.1002\/ccr3.4568","journal-title":"Clin Case Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2020.598846","article-title":"Prevalence of venous thromboembolism in critically Ill COVID-19 patients: systematic review and meta-analysis","volume":"7","author":"Mohamed MF","year":"2020","unstructured":"Mohamed MF, Al-Shokri SD, Shunnar KM, et al.. Prevalence of venous thromboembolism in critically Ill COVID-19 patients: systematic review and meta-analysis\r\n. Front Cardiovasc Med. 2020, 7:598846. 10.3389\/fcvm.2020.598846","journal-title":"Front Cardiovasc Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.926062","article-title":"Chronic lymphocytic leukemia concomitant with COVID 19: a case report","volume":"21","author":"Ali E","year":"2020","unstructured":"Ali E, Badawi M, Abdelmahmuod E, Kohla S, Yassin MA. Chronic lymphocytic leukemia concomitant with COVID 19: a case report. Am J Case Rep. 2020, 21:e926062. 10.12659\/AJCR.926062","journal-title":"Am J Case Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0959-x","article-title":"COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus","volume":"34","author":"Scarf\u00f2 L","year":"2020","unstructured":"Scarf\u00f2 L, Chatzikonstantinou T, Rigolin GM, et al.. COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus. Leukemia. 2020, 34:2354-63. 10.1038\/s41375-020-0959-x","journal-title":"Leukemia"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24387","article-title":"Comorbidities and mortality rate in COVID-19 patients with hematological malignancies: a systematic review and meta-analysis","volume":"36","author":"Naimi A","year":"2022","unstructured":"Naimi A, Yashmi I, Jebeleh R, et al.. Comorbidities and mortality rate in COVID-19 patients with hematological malignancies: a systematic review and meta-analysis. J Clin Lab Anal. 2022, 36:e24387. 10.1002\/jcla.24387","journal-title":"J Clin Lab Anal"},{"key":"ref10","unstructured":"Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. (2022). Accessed. May 5, 2022: https:\/\/www.covid19treatmentguidelines.nih.gov\/."},{"key":"ref11","unstructured":"Enhancing readiness for Omicron (B.1.1.529). Technical brief and priority actions for Member States World Health Organization HQ . (2021). Accessed: May 5, 2022: https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/2021-12-23-global-technical-brief-and-priority-action-on-omicron...."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1101\/2021.11.11.21266068","article-title":"Increased risk of SARS-CoV-2 reinfection associated with emergence of the Omicron variant in South Africa [Preprint]","author":"Pulliam JR","year":"2021","unstructured":"Pulliam JR, van Schalkwyk C, Govender N, et al.. Increased risk of SARS-CoV-2 reinfection associated with emergence of the Omicron variant in South Africa [Preprint]. MedRxiv. 2021, 10.1101\/2021.11.11.21266068","journal-title":"MedRxiv"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2021.12.357","article-title":"Decreased severity of disease during the first global omicron variant covid-19 outbreak in a large hospital in tshwane, South Africa","volume":"116","author":"Abdullah F","year":"2022","unstructured":"Abdullah F, Myers J, Basu D, et al.. Decreased severity of disease during the first global omicron variant covid-19 outbreak in a large hospital in tshwane, South Africa. Int J Infect Dis. 2022, 116:38-42. 10.1016\/j.ijid.2021.12.357","journal-title":"Int J Infect Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.23863","article-title":"SARS-CoV-2 Omicron variant in patients with chronic myeloid leukemia: a retrospective study","volume":"14","author":"Ali EA","year":"2022","unstructured":"Ali EA, Khamees I, Abu-Tineh M, et al.. SARS-CoV-2 Omicron variant in patients with chronic myeloid leukemia: a retrospective study. Cureus. 2022, 14:e23863. 10.7759\/cureus.23863","journal-title":"Cureus"},{"key":"ref15","article-title":"COVID-19 infection in patients with acute leukemia; Istanbul experience","volume":"11","author":"Buyuktas D","year":"2021","unstructured":"Buyuktas D, Acar K, Sucak G, et al.. COVID-19 infection in patients with acute leukemia; Istanbul experience. Am J Blood Res. 2021, 11:427-37.","journal-title":"Am J Blood Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1101\/2021.04.06.21254949","article-title":"Suboptimal response to COVID-19 mRNA vaccines in hematologic malignancies patients","author":"Agha M","year":"2021","unstructured":"Agha M, Blake M, Chilleo C, Wells A, Haidar G. Suboptimal response to COVID-19 mRNA vaccines in hematologic malignancies patients. medRxiv. 2021, 10.1101\/2021.04.06.21254949","journal-title":"medRxiv"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/97269-a-case-series-of-sars-cov-2-omicron-variant-in-patients-with-acute-leukemia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:43:41Z","timestamp":1707507821000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/97269-a-case-series-of-sars-cov-2-omicron-variant-in-patients-with-acute-leukemia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,21]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.25196","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5,21]]}}}